Anti-human cytomegalovirus (CMV) monoclonal antibody (MAb) F6b produced by clone 95/12 was used for the rapid diagnosis (16 to 24 h) of CMV isolates in 308 clinical specimens and compared with classic isolation. MAb F6b gave 100% correlation with isolation. When this MAb was used for direct diagnosis with 212 urine and bronchoalveolar specimens, detection of CMV varied from 50 to 75% compared with viral isolation.
Cytomegalovirus (CMV) is responsible for a wide spectrum of serious clinical disorders. Infection with this virus causes congenital malformations and leads to death and graft rejection in organ transplant recipients (20, 26) .
Identification of CMV infection was initially dependent on viral isolation in sensitive cell cultures of human fibroblasts (12, 13) and appearance of cytopathic effects. This requires long incubation times (up to 4 weeks) and blind passaging of cells.
There has been much interest in the use of monoclonal antibodies (MAbs) for the rapid and specific diagnosis of human viral (4, 5, 9, 15, 19, 28) and chlamydial (14, 24, 25) infections, including CMV (1, 3, 6, 10, 11, 18, (21) (22) (23) 27) . Direct assay of clinical specimens is particularly important for identification of pathogenic agents that are characterized by slow growth in culture.
We have tested the specificity and sensitivity of a recently described MAb (2, 16, 17) for the early detection of virus in cell cultures inoculated for isolation and for the detection of CMV directly in specimens. The MAb used, F6b produced by clone 95/12, recognizes a protein of 68 kilodaltons (16) which appears 3 h after infection (2) and persists throughout the replicative cycle. It is first seen in the nuclei of infected cells. About 24 h after infection, it is also detected in the cytoplasm where it accumulates to such an extent that nuclear fluorescence is masked by intense whole-cell fluorescence (2, 16) . This MAb is available in kit form under the name of Monofluo CMV (Diagnostics Pasteur).
The immunofluorescence assay was performed by using Monofluo CMV kits according to the instructions of the manufacturer. Briefly, infected and control, uninfected cells on glass slides were fixed in acetone at -20°C for 10 min after being air dried. Fixed cells were incubated with MAb F6b (ready for use in the kit), followed by incubation with fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin G solution containing Evans blue counterstain, which is also supplied in the kit. All incubations were done at 37°C for 30 min. Slides were washed twice after each application of antibody for 5 min with phosphate-buffered saline at pH 7.8. The slightly alkaline pH of phosphate-* Corresponding author. buffered saline reduces nonspecific fluorescence. Preparation of cells used in sensitivity assays was done as follows. Confluent monolayers of human diploid embryonic fibroblasts grown in 25-cm2 flasks or shell vials in Eagle basic medium and 10% fetal bovine serum were inoculated with 2 ml of urine or bronchoalveolar washing (BAW) or 1 ml of saliva. Flasks were centrifuged at 1,500 x g and shell vials were centrifuged at 4,000 x g for 1 to 1.5 h (see below). The inoculum was eliminated, and the cells were washed and fed medium containing 2% fetal bovine serum and incubated for 16 to 24 h at 37°C. At the end of the incubation period, the cells were examined microscopically or were harvested, attached by drying onto glass slides, and then fixed in acetone and incubated as indicated above with MAb F6b.
All clinical specimens were taken from patients hospitalized in France either at the Centre Hospitalier Régional et Universitaire of the Timone Hospital at the University of Marseille (laboratory 1) or at the Sablon Hospital of the University of Grenoble (laboratory 2) ( (1, (6) (7) (8) 10) .
For conventional isolation, flasks were observed for development of cytopathic effects every other day for 21 days. Sensitivity was very dependent on the condition of the cells examined. Urinary material had nearly always deteriorated. Detection in urine specimens (50%) was lower than that in BAWs (75%) ( Table 4) .
This study showed that MAb F6b is a very specific reagent for the rapid diagnosis of CMV. The virus can be detected Table 3 . Specimens used by laboratory 1 were the same as those shown in Table 3 , except that 50 additional CMV-positive urinary specimens were tested here by direct diagnosis.
well before the appearance of cytopathic effects within 16 to 24 h after the inoculation of fibroblasts. Efficiency of detection correlated 100% with conventional isolation. This antibody can also be used to detect CMV directly in clinical specimens.
